NCT06732128Recruiting
Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease
Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease: a Pilot Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 13 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Behavioural and psychological symptoms of dementia (BPSD), such as depression affect up to 90% patients with dementia. Non-pharmacological treatment of BPSD, can be difficult to access, require caregiver support, travel, and often have long waiting lists. Virtual reality (VR) is an innovative, portable, immersive, and accessible technology which can be used in-home. More information is required on the feasibility of using VR in-home with older adults with dementia. Our study will offer a 4-week program of 15-minutes sessions, twice per week nature-based VR program for BPSD delivered in-home by virtual reality (VR). Additionally, caregivers will have the option of taking part in the study and provide feedback regarding the VR intervention. If successful, this project has the potential to prolong aging in place for individuals with BPSD, as BPSD is a significant factor in institutionalization.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 19 Nov 2024
- Start date
- 6 Jan 2025
- Primary completion date
- 11 Jun 2025
- Lead sponsor
- Centre for Addiction and Mental Health
- Diseases
- Alzheimer disease
- NCT number
- NCT06732128
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 6 Jan 2025 to the primary completion date, 11 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unstable medical or psychiatric condition, including substance use based on an investigator opinion
- Patient Health Questionnaire score 15-27 and/or score of 1 or 2 in section E question 1 of the Cornell Scale for Depression in Dementia
Other
- Visual or hearing impairments that would impair participation
- Any other reason, which will make the study participation intolerable for the participant in the opinion of the study investigator
Who the study is looking for
- Clinical diagnosis of mild to early-moderate stage AD (including mixed dementia with AD) using the Diagnostic and Statistical Manual of Mental Disorders, 5th Ed. Criteria
- Age of 50 years or older
- Medical stability to participate in the trial
- Patient Health Questionnaire score 5-14
- Investigator judgement on whether the participant is comfortable with technology
- Access to WiFi and a smart device for connecting on WebEx and downloading the Fitbit and Muse applications
- Have someone available to be present during all sessions
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Addictions and Mental Health (CAMH) Coordinator of this site? Confirm its status | Toronto | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.